Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Urogenital Neoplasms 2Colitis 2Carcinoma, Non-Small-Cell Lung 2Takayasu Arteritis 1Melanoma 1Lung Neoplasms 1Inflammatory Bowel Diseases 1Crohn Disease 1Colitis, Ulcerative 1

Interventions

Nivolumab 2Infliximab 2Educational Status 2Colonoscopy 2vedolizumab 1pembrolizumab 1golimumab 1Vitamin E 1Sutures 1Surgical Instruments 1Standard of Care 1Specimen Handling 1Ringer's Lactate 1Proctocolectomy, Restorative 1Proctectomy 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Papillomavirus Vaccines 1Narrow Band Imaging 1Methods 1Lysine Acetyltransferase 5 1Loperamide 1Laparoscopy 1Iron-Dextran Complex 1Interviews as Topic 1Indigo Carmine 1Hydroxyethyl Starch Derivatives 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Endoscopy 1Eicosapentaenoic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Colitis, Ulcerative × CT-P13 × Clear all
NCT04646187 2025-01-06

FREE

University Medical Center Groningen

Phase 4 Enrolling by invitation
148 enrolled

Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡